Resibufogenin suppresses transforming growth factor‐β‐activated kinase 1‐mediated nuclear factor‐κB activity through protein kinase C‐dependent inhibition of glycogen synthase kinase 3

Resibufogenin (RB), one of the major active compounds of the traditional Chinese medicine Chansu, has received considerable attention for its potency in cancer therapy. However, the anticancer effects and the underlying mechanisms of RB on pancreatic cancer remain elusive. Here, we found that RB inh...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Sci
Hoofdauteurs: Liu, Lu, Liu, Yang, Liu, Xiaojia, Zhang, Na, Mao, Genxiang, Zeng, Qingxuan, Yin, Mingxiao, Song, Danqing, Deng, Hongbin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2018
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215888/
https://ncbi.nlm.nih.gov/pubmed/30168902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13788
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items